申请人:Nektar Therapeutics
公开号:US10265411B2
公开(公告)日:2019-04-23
The invention relates to (among other things) N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
本发明涉及(除其他外)N-可选取代的芳基-2-寡聚体-3-烷氧基丙酰胺及其组合物。与缺乏低聚物的相应化合物相比,本发明的化合物在通过多种给药途径中的任何一种给药时,都具有一种或多种优点。